本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Autolus Therapeutics PLC

1.53
-0.1300-7.83%
盤後1.550.0181+1.18%19:47 EDT
成交量:146.19萬
成交額:226.67萬
市值:4.07億
市盈率:-1.42
高:1.66
開:1.66
低:1.51
收:1.66
52周最高:2.70
52周最低:1.18
股本:2.66億
流通股本:1.19億
量比:0.87
換手率:1.23%
股息:- -
股息率:- -
每股收益(TTM):-1.0804
每股收益(LYR):-1.0804
淨資產收益率:-120.42%
總資產收益率:-25.96%
市淨率:3.74
市盈率(LYR):-1.42

資料載入中...

公司資料

公司名字:
Autolus Therapeutics PLC
交易所:
NASDAQ
成立時間:
2014
員工人數:
753
公司地址:
The Mediaworks,191 Wood Lane,White City,London,Greater London,United Kingdom
郵編:
W12 7FP
傳真:
- -
簡介:
Autolus Therapeutics plc於2018年2月2日在英格蘭和威爾士註冊成立。該公司是一家處於早期商業化階段的生物製藥公司,致力於開發用於癌症和自身免疫性疾病的下一代T細胞療法。其主要產品AUCATZYL(obe-cel)是一種靶向CD19的嵌合抗原受體T細胞療法,已在美國和英國獲批用於治療複發或難治性B細胞前體急性淋巴細胞白血病。

董事

名稱
職位
Christian Itin
Chief Executive Officer and Director
Michael Bonney
Chairman of the Board
Cynthia Butitta
Director
Elisabeth Leiderman
Director
John Berriman
Director
Linda Bain
Director
Ravi Rao
Director
Robert Azelby
Director
Robert Iannone
Director
Ryan Richardson
Director
William Young
Director

股東

名稱
職位
Christian Itin
Chief Executive Officer and Director
Christopher Vann
Chief Operating Officer and Senior Vice President
Alex Driggs
General Counsel and Senior Vice President, Legal Affairs
Alexander Swan
Chief Human Resources Officer and Senior Vice President
Christopher Williams
Chief Business Development Officer and Senior Vice President
Cintia Piccina
Senior Vice President and US Chief Commercial Officer and Country GM
Martin Pulé
Chief Scientific Officer and Senior Vice President
Matthias Will
Chief Development Officer and Senior Vice President
Miranda Neville
Chief Technology Officer and Senior Vice President
Patrick McIlvenny
Chief Accounting Officer and Senior Vice President, Finance
Robert Dolski
Chief Financial Officer and Senior Vice President